ADVERUM BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • August 5th, 2021 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between Julie Christine Clark, M.D. (“Executive”) and Adverum Biotechnologies, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).
Adverum Biotechnologies, Inc. Letterhead]Adverum Biotechnologies, Inc. • August 5th, 2021 • Biological products, (no disgnostic substances) • California
If you decide to join us, this letter agreement (the “Agreement”) memorializes your compensation and other employment terms. These terms will become effective on the date you join the Company (the “Hire Date”).
FIRST AMENDMENT TO LEASELease • August 5th, 2021 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances)
This FIRST AMENDMENT TO LEASE ("First Amendment") is made and entered into as of April 19, 2021 (the “Effective Date”), by and between HCP LS REDWOOD CITY, LLC, a Delaware limited liability company ("Landlord"), and ADVERUM BIOTECHNOLOGIES, INC., a Delaware corporation ("Tenant").
Consulting AgreementConsulting Agreement • August 5th, 2021 • Adverum Biotechnologies, Inc. • Biological products, (no disgnostic substances) • California
This Consulting Agreement (the “Agreement”) is made and entered into as of June 24, 2021 (the “Effective Date”), by and between Adverum Biotechnologies, Inc., a Delaware corporation with an address at 800 Saginaw Drive, Redwood City, CA 94063 (the “Company”), and Leone Patterson, an individual, (the “Consultant”).
